Date: May 20, 2021
Time: 6:00am (PDT), 9:00am (EDT), 2:00pm (BST)
In this webinar, Dr Rachel Marrington, Deputy Director, and Finlay MacKenzie, Director, at Birmingham Quality UK NEQAS, will give an overview of the common interferences seen in the laboratory: Haemolysis, Icterus and Lipemia (HIL). Rachel and Finlay will present the results of a large study UK NEQAS has coordinated supported by Ortho Clinical Diagnostics, which looks at the effect of HIL on several common biochemistry analytes across different platforms.
In the second part of this webinar, Natalie Mullee, Principal Clinical Scientist at the Royal Marsden NHS Foundation Trust UK, will talk about the electrolyte exclusion effect and the advantages of using direct ion selective electrode (ISE)-based technologies, in particular when analysing samples from cancer patients.
To round off the webinar, Els Melis, EMEA Senior Marketing Manager Clinical Labs Assays at Ortho Clinical Diagnostics, will describe how VITROS® technology can help minimise the impact of interferences.
- Explain the different types of interferences a laboratory can encounter and how they can affect certain assays
- Outline the differences between direct and indirect ISE, and address discrepancies in electrolyte measurements between both methods
- Evaluate how VITROS® technologies have been designed to address such challenging samples
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.